Project

General

Profile

Projects

Filters

Apply Clear

  • TIDE - Cameroon - Y4

    The Translating Data and Evidence into Impact (TIDE) Program has been designed and will be implemented to achieve the purpose and strategies of CDC funding opportunity: Targeted Programmatic Support Across Countries under Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria under the President's Emergency Plan for AIDS Relief (PEPFAR). Georgetown University, under the auspices of the Center for Global Health Practice and Impact (CGHPI) has received CDC Cooperative Agreement award number U2GGH002214 to implement TIDE in Cameroon, Haiti, and the Western Hemisphere. TIDE is a Global Program Support and Assistance (PSA) mechanism designed to support countries’ efforts to achieve and sustain HIV epidemic control. The purpose of TIDE program assistance in Cameroon is to implement HIV prevention, care, and treatment services across the clinical cascade for adult and pediatric, general, and key populations to achieve HIV epidemic control. The effectiveness of TIDE will be measured by several outcomes including; increased HIV testing yield, new PLHIV diagnosed, linked to care, treated, retained, and virally suppressed; increased prevention of mother to child transmission (PMTCT) services and early infant diagnosis (EID); increased access and uptake of comprehensive HIV services for hard to reach populations; improved capacity of government institutions at regional and district levels to provide oversight and quality assure comprehensive HIV and TB/HIV services; increased capacity of health facilities and health care delivery teams to use data and evidence to improve quality of care for all patients and improve efficiency and effectiveness in care delivery systems, and; increased capacity at all levels of the care system to collect, analyze, use, and report programmatic and client level data. From September 30, 2019 through September 29, 2020, TIDE will enroll at least 38,957 new clients on ART, maintain a total of 115,540 PLHIV on treatment, and ensure at least 97,991 PLHIV receiving treatment are virally suppressed (85% of 115,540)....

Also available in: Atom